← Leaderboards
T John Winhusen
University Of Cincinnati
$49,288,989
Attributed
$82,422,689
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $25.1M · FY2011–25$50M$37.5M$25M$12.5M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$115,922,187 · 8
By mechanism
UM1$66,267,400 · 1
UG1$35,117,390 · 4
U10$11,376,286 · 1
R01$2,480,792 · 1
R34$680,319 · 1
Top collaborators
- Rebecca D Jackson3 shared
- Bridget Freisthler2 shared
Others in their field
Top investigators on “National Institute Of Drug Abuse”
- Barbara Driver · Westat, Inc.$95,724,261
- Jeffrey H Samet · Boston University Medical Campus$90,210,613
- Paul Vanveldhuisen · The Emmes Company, Llc$63,018,753
- Lloyd D Johnston · University Of Michigan At Ann Arbor$60,310,192
- Robert Lindblad · The Emmes Company, Llc$49,324,035
- Richard A Miech · Johns Hopkins University$46,450,970
Research focus
National Institute Of Drug AbuseBaseOhioClinical Trials NetworkOpioidAddictionResearch PersonnelSiteBuprenorphineMemberPrimary Health CareDesignClinical TrialsCaringLeadershipConduct Clinical TrialsAccident And Emergency DepartmentHealth PersonnelPharmaceutical PreparationsCollaborationsCommunitiesElectronic Health RecordParticipantOverdose
Grant awards (61)
The Ohio Valley Node of the Clinical Trials Network$7,799,687
UG1 · FY2025 · DA · contact PI
The Ohio Valley Node of the Clinical Trials Network (CTN-0153)$723,623
UG1 · FY2025 · DA · contact PI
The Ohio Valley Node of the Clinical Trials Network$2,152,484
UG1 · FY2024 · DA · contact PI
Project-002$1,118,348
UG1 · FY2024 · DA · contact PI
CTN - Effects of semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro and Zepbound) on incidence and outcomes of stimulant use disorders and opioid use disorder in real-world populations: target tr$502,744
UG1 · FY2024 · DA · contact PI
CTN - Evaluation of SeMaglutide as an Adjunct to buprenorphine treatment for the treatment of opioid use disorder: A pragmatic Randomized placebo-controlled Trial (SMART)$498,507
UG1 · FY2024 · DA · contact PI
Project-004$284,894
UG1 · FY2024 · DA · contact PI
Project-003$214,650
UG1 · FY2024 · DA · contact PI
IMPROVE$146,310
UG1 · FY2024 · DA · contact PI
Optimizing HEALing in Ohio Communities (OHiO)-Health Equity Supplement$799,825
UM1 · FY2023 · DA
The Ohio Valley Node of the Clinical Trials Network$1
UG1 · FY2023 · DA · contact PI
Optimizing HEALing in Ohio Communities (OHiO)$6,070,000
UM1 · FY2022 · DA
The Ohio Valley Node of the Clinical Trials Network$1,537,390
UG1 · FY2022 · DA · contact PI
The Ohio Valley Node of the Clinical Trials Network$768,017
UG1 · FY2022 · DA · contact PI
The Ohio Valley Node of the Clinical Trials Network$502,461
UG1 · FY2022 · DA · contact PI
The Ohio Valley Node of the Clinical Trials Network$378,965
UG1 · FY2022 · DA · contact PI
Optimizing HEALing in Ohio Communities (OHiO)$18,989,589
UM1 · FY2021 · DA
The Ohio Valley Node of the Clinical Trials Network$1,446,804
UG1 · FY2021 · DA · contact PI
The Ohio Valley Node of the Clinical Trials Network$1,198,077
UG1 · FY2021 · DA · contact PI
The Ohio Valley Node of the Clinical Trials Network$900,438
UG1 · FY2021 · DA · contact PI
EMPOWER: Evaluating the ability to reduce Morphine equivalent dose for chronic Pain patients receiving Opioid-therapy through a Web-based E-Health self-management program: a Randomized multi-site Clin$413,732
R01 · FY2021 · DA · contact PI
The Ohio Valley Node of the Clinical Trials Network$33,244
UG1 · FY2021 · DA · contact PI
Optimizing HEALing in Ohio Communities (OHiO)$20,779,319
UM1 · FY2020 · DA
The Ohio Valley Node of the Clinical Trials Network$2,424,851
UG1 · FY2020 · DA · contact PI
The Ohio Valley Node of the Clinical Trials Network$982,781
UG1 · FY2020 · DA · contact PI
EMPOWER: Evaluating the ability to reduce Morphine equivalent dose for chronic Pain patients receiving Opioid-therapy through a Web-based E-Health self-management program: a Randomized multi-site Clin$481,743
R01 · FY2020 · DA · contact PI
The Ohio Valley Node of the Clinical Trials Network$411,680
UG1 · FY2020 · DA · contact PI
Optimizing HEALing in Ohio Communities (OHiO)$19,628,667
UM1 · FY2019 · DA
Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network$2,457,513
UG1 · FY2019 · DA · contact PI
Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network$725,165
UG1 · FY2019 · DA · contact PI
Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network$652,568
UG1 · FY2019 · DA · contact PI
EMPOWER: Evaluating the ability to reduce Morphine equivalent dose for chronic Pain patients receiving Opioid-therapy through a Web-based E-Health self-management program: a Randomized multi-site Clin$483,640
R01 · FY2019 · DA · contact PI
Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network$315,312
UG1 · FY2019 · DA · contact PI
Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network$251,946
UG1 · FY2019 · DA · contact PI
Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network$160,705
UG1 · FY2019 · DA · contact PI
Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network$1,039,597
UG1 · FY2018 · DA · contact PI
Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network$940,908
UG1 · FY2018 · DA · contact PI
Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network$739,260
UG1 · FY2018 · DA · contact PI
EMPOWER: Evaluating the ability to reduce Morphine equivalent dose for chronic Pain patients receiving Opioid-therapy through a Web-based E-Health self-management program: a Randomized multi-site Clin$482,547
R01 · FY2018 · DA · contact PI
Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network$318,750
UG1 · FY2018 · DA · contact PI
A tailored, peer-delivered intervention to reduce recurring opioid overdoses$190,000
R34 · FY2018 · DA · contact PI
Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network$756,329
UG1 · FY2017 · DA · contact PI
Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network$622,479
UG1 · FY2017 · DA · contact PI
EMPOWER: Evaluating the ability to reduce Morphine equivalent dose for chronic Pain patients receiving Opioid-therapy through a Web-based E-Health self-management program: a Randomized multi-site Clin$619,130
R01 · FY2017 · DA · contact PI
A tailored, peer-delivered intervention to reduce recurring opioid overdoses$265,169
R34 · FY2017 · DA · contact PI
Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network$776,395
UG1 · FY2016 · DA · contact PI
A tailored, peer-delivered intervention to reduce recurring opioid overdoses$225,150
R34 · FY2016 · DA · contact PI
Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network$789,514
UG1 · FY2015 · DA · contact PI
Clinical Trials Network, Ohio Valley Node U10DA013732$623,171
U10 · FY2015 · DA · contact PI
Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network$357,732
UG1 · FY2015 · DA · contact PI
Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network$187,261
UG1 · FY2015 · DA · contact PI
Clinical Trials Network, Ohio Valley Node U10DA013732$2,042,401
U10 · FY2014 · DA · contact PI
Clinical Trials Network, Ohio Valley Node U10DA013732$1,148,296
U10 · FY2014 · DA · contact PI
Clinical Trials Network, Ohio Valley Node U10DA013732$1,154,837
U10 · FY2013 · DA · contact PI
Clinical Trials Network, Ohio Valley Node U10DA013732$1,129,841
U10 · FY2013 · DA · contact PI
Clinical Trials Network, Ohio Valley Node U10DA013732$688,350
U10 · FY2013 · DA · contact PI
Clinical Trials Network, Ohio Valley Node U10DA013732$1,154,735
U10 · FY2012 · DA · contact PI
Clinical Trials Network, Ohio Valley Node U10DA013732$880,000
U10 · FY2012 · DA · contact PI
Clinical Trials Network, Ohio Valley Node U10DA013732$633,443
U10 · FY2012 · DA · contact PI
Clinical Trials Network, Ohio Valley Node U10DA013732$1,176,978
U10 · FY2011 · DA · contact PI
Clinical Trials Network, Ohio Valley Node U10DA013732$744,234
U10 · FY2011 · DA · contact PI